Projects
-
Innovative Medicines Initiative 2 Joint EU: Autism Innovative Medicine Studies – 2 – Trials’ —‘AIMS-2-TRIALS’
- Leader
- Mercedes Serrano Gimaré
- Announcement
- H2020-JTI-IMI2-2016-10-two-stage, IMI2_EAGER
- Code
- 777394
- Starting date
- 2023
- End date
- 2025
- Funded by
- European Commission, King's College London